{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F632024-fmiso-IT8JJ7xW","width":444,"version":"1.0","type":"rich","title":"6.3.2024 - FMISO","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/efcb05a5-2fa6-42f6-b5f9-4bcd3d8e2fec\" height=\"200\" width=\"100%\" title=\"6.3.2024 - FMISO\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Check out this week's Quadcast where we highlight the role of FMISO PET to identify tumor hypoxia for attempts at dose de-escalation in HPV mediated HNSCC, ASTRO's new guidelines on bone metastasis treatment, SBRT for mediastinal LNs, and more."}